SciVision Biotech

SciVision Biotech EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of SciVision Biotech (1786.TW) as of Oct 20, 2026 is 35.36. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 15.96 — a change of 121.60% (higher).

EV/OCF

35.36

YoY

121.60%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of SciVision Biotech is 2025 35.36 . EV/OCF (Enterprise Value to Operating Cash Flow) of SciVision Biotech was 2024 15.96 . It decreases by 121.60% higher compared to the previous year.

The SciVision Biotech EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
44.15 TWD
Jan 1, 2019
23.66 TWD
Jan 1, 2020
38.44 TWD
Jan 1, 2021
49.65 TWD
Jan 1, 2022
26.33 TWD
Jan 1, 2023
16.53 TWD
Jan 1, 2024
15.96 TWD
Jan 1, 2025
35.36 TWD
The SciVision Biotech EV/OCF history
YEAREV/OCFYoY
35.36+121.60%
15.96-3.49%
16.53-37.20%
26.33-46.97%
49.65+29.17%
38.44+62.45%
23.66-46.41%
44.15-86.18%
319.56+155.42%
125.11+37.16%
91.21-96.02%
2,293.46—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SciVision Biotech Stock analysis

What does SciVision Biotech do? SciVision Biotech Inc, based in Kaohsiung, Taiwan, specializes in the research, development, and production of hyaluronic acid medical products. The company offers subcutaneous fillers for plastic surgery, joint cavity injections for orthopedics, and hyaluronic acid raw materials. It also provides DNA identification, detection, sequencing, and related applications, alongside care products and food manufacturing. SciVision Biotech operates globally across the Americas, Europe, Asia, the Middle East, and Africa. SciVision Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SciVision Biotech stock

EV/OCF (Enterprise Value to Operating Cash Flow) of SciVision Biotech is 35.36 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of SciVision Biotech changed from 15.96 to 35.36, representing a 121.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) SciVision Biotech since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s SciVision Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — SciVision Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — SciVision Biotech